Finland Pharmaceuticals & Healthcare Q2 2018
Finland's economic outlook remains sanguine as robust activity in trade and investment will carry into the comingquarters and support pharmaceutical growth in 2018. Although small by Western standards, Finland will remain relatively attractivemarket for innovative drugmakers over the next decade owing to an aging population and high per-capita spending. However, theimpending health reforms will see the government enact further cost-saving initiatives that heavily target high-value medicines.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook